Compare FHN & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FHN | BAX |
|---|---|---|
| Founded | 1864 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 9.4B |
| IPO Year | N/A | N/A |
| Metric | FHN | BAX |
|---|---|---|
| Price | $24.10 | $19.14 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 18 | 10 |
| Target Price | $24.50 | ★ $25.67 |
| AVG Volume (30 Days) | 5.5M | ★ 8.2M |
| Earning Date | 01-15-2026 | 10-30-2025 |
| Dividend Yield | ★ 2.51% | 0.21% |
| EPS Growth | ★ 20.88 | N/A |
| EPS | ★ 1.65 | N/A |
| Revenue | $3,184,000,000.00 | ★ $11,023,000,000.00 |
| Revenue This Year | $12.70 | $5.20 |
| Revenue Next Year | $2.54 | $2.02 |
| P/E Ratio | $14.42 | ★ N/A |
| Revenue Growth | 3.68 | ★ 3.90 |
| 52 Week Low | $15.19 | $17.40 |
| 52 Week High | $24.11 | $37.74 |
| Indicator | FHN | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 70.38 | 51.04 |
| Support Level | $23.54 | $18.82 |
| Resistance Level | $24.10 | $19.82 |
| Average True Range (ATR) | 0.46 | 0.50 |
| MACD | 0.11 | 0.19 |
| Stochastic Oscillator | 94.64 | 62.37 |
First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.